NDC 68084-952-95 - Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-952
- Requested NDC
- 68084-952-95
- Package NDCs from labels
- 68084-952-95, 68084-952-25
- Manufacturer
- American Health Packaging
- Effective date
- 2024-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Sulfate - American Health Packaging | American Health Packaging | 2024-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-952-25 | Albuterol Sulfate | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 5 | |
| 68084-952-95 | Albuterol Sulfate | 1 in 1 BLISTER PACK | TABLET | 1 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-952-25 | EA - Each | 68084-952 | 10932747-c4cb-4e52-981f-44aee28ec466 | 1 | 2015-11-12 |
| 68084-952-95 | EA - Each | 68084-952 | 74e13657-2856-4a7c-a03d-05342393dbb1 | 1 | 2015-11-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| albuterol sulfate | ACTIVE INGREDIENT | 021SEF3731 | ALBUTEROL SULFATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| albuterol | ACTIVE MOIETY | QF8SVZ843E | ALBUTEROL SULFATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| anhydrous lactose | INACTIVE INGREDIENT | 3SY5LH9PMK | ALBUTEROL SULFATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | ALBUTEROL SULFATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| sodium starch glycolate type a potato | INACTIVE INGREDIENT | 5856J3G2A2 | ALBUTEROL SULFATE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | ALBUTEROL SULFATE TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 922bf33b-4d55-4c35-9f68-72efbb17c14f | 2024-02-21 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | A-S Medication Solutions | 7ad17b39-d2de-4108-abbf-cedd650c8edd | 2024-02-18 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Cipla USA Inc. | 89d59bd9-c826-413c-8ed9-a1521a0c7cc5 | 2024-01-11 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Proficient Rx LP | a1d9d346-91a5-4f5a-82ed-4ebeaf350a06 | 2024-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Asclemed USA, Inc. | a69489f7-4ffb-4cd1-b2d2-002f48e84f51 | 2023-12-19 | Boxed warning, Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Aurobindo Pharma Limited | 370516c4-718f-4a71-bdc8-8822060ccefe | 2023-10-31 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 07b1ee8b-d920-49dd-9fad-cb0fe8a35e0d | 2023-10-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate HFA | ALBUTEROL SULFATE | Proficient Rx LP | d617e361-5c03-45ac-9bbe-0fa418edb19f | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 021SEF3731 |
| VENTOLIN HFA | ALBUTEROL SULFATE | Proficient Rx LP | 6dc143e7-6bab-42c8-b3e9-9d604d202e73 | 2023-10-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Zydus Pharmaceuticals USA Inc. | c3fa0068-fd12-45de-818e-e929fb45ba05 | 2023-08-21 | Warnings, Adverse reactions | 197316 197318 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | A-S Medication Solutions | 8f52f15f-3fb7-4b00-a19f-8721c5ac55db | 2023-07-24 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Chartwell RX, LLC | 81cdae6f-99d7-468b-9ab8-fecb1d42298d | 2023-06-19 | Warnings, Adverse reactions | 197316 197318 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Medical Purchasing Solutions, LLC | 6a4b4b95-d1d3-9051-e053-2a91aa0a52e8 | 2023-05-30 | Warnings, Adverse reactions | 021SEF3731 |
| albuterol sulfate HFA | ALBUTEROL SULFATE | A-S Medication Solutions | 4378c5b0-529f-44b4-bdf1-e9f2631df8cd | 2023-02-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Hikma Pharmaceuticals USA Inc. | 6c64ab5d-f8a2-440a-a929-cb8188d0e8b4 | 2023-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Proficient Rx LP | 4100bce5-096c-42e4-9e4e-d11a0ab597d5 | 2023-01-01 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Aurobindo Pharma Limited | ff9b287b-e4a4-4c12-ad2f-6b7d55b20dc6 | 2022-12-15 | Warnings, Adverse reactions | 197316 197318 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 87ff8be7-3a49-44bd-92de-eb8db24af95b | 2022-12-13 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | HF Acquisition Co LLC, DBA HealthFirst | ad299502-8779-d280-e053-2995a90a7371 | 2022-12-10 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Proficient Rx LP | 0b0587df-b4bd-4fae-9d79-c71362c0314b | 2022-12-01 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.